- Report
- July 2026
- 90 Pages
Europe
From €4325EUR$4,750USD£3,710GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- April 2026
- 142 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- July 2026
- 120 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- March 2026
- 150 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- December 2025
- 150 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- October 2025
- 97 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- April 2026
- 401 Pages
Global
From €4507EUR$4,950USD£3,866GBP
- Report
- June 2026
- 453 Pages
Global
From €4507EUR$4,950USD£3,866GBP
- Report
- November 2025
- 302 Pages
Global
From €4507EUR$4,950USD£3,866GBP
- Report
- March 2026
- 1295 Pages
Global
€1448EUR$1,646USD£1,200GBP
- Report
- July 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- April 2026
- 200 Pages
Global
From €2722EUR$2,990USD£2,335GBP
- Report
- April 2026
- 200 Pages
Global
From €2722EUR$2,990USD£2,335GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more